These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34408076)

  • 1. Optimized delay of the second COVID-19 vaccine dose reduces ICU admissions.
    Silva PJS; Sagastizábal C; Nonato LG; Struchiner CJ; Pereira T
    Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34408076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of COVID-19 vaccination strategies with a delayed second dose.
    Moghadas SM; Vilches TN; Zhang K; Nourbakhsh S; Sah P; Fitzpatrick MC; Galvani AP
    PLoS Biol; 2021 Apr; 19(4):e3001211. PubMed ID: 33882066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC
    BMJ; 2021 May; 373():n1087. PubMed ID: 33980718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
    Hupert N; Marín-Hernández D; Gao B; Águas R; Nixon DF
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing fractional doses of COVID-19 vaccines.
    Więcek W; Ahuja A; Chaudhuri E; Kremer M; Simoes Gomes A; Snyder CM; Tabarrok A; Tan BJ
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2.
    Souto Ferreira L; Canton O; da Silva RLP; Poloni S; Sudbrack V; Borges ME; Franco C; Marquitti FMD; de Moraes JC; Veras MASM; Kraenkel RA; Coutinho RM
    PLoS Comput Biol; 2022 Mar; 18(3):e1009978. PubMed ID: 35333872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the dose-effect association between the number of doses and duration since the last dose of COVID-19 vaccine, and its efficacy in preventing the disease and reducing disease severity: A single centre, cross-sectional analytical study from India.
    Bhattacharya A; Ranjan P; Ghosh T; Agarwal H; Seth S; Maher GT; Upadhyay AD; Kumar A; Baitha U; Gupta G; Prakash B; Dwivedi SN; Wig N
    Diabetes Metab Syndr; 2021; 15(5):102238. PubMed ID: 34364299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
    Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
    EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
    [No Abstract]   [Full Text] [Related]  

  • 12. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccines: what happened to evidence-based medicine?
    Quek E; Tahir H
    Br J Hosp Med (Lond); 2021 Feb; 82(2):1-4. PubMed ID: 33646036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of vaccination on ICU admissions of hospitalized COVID-19 patients in a country with a heterologous vaccine policy.
    Yıldırım S; Kirakli C; Özdemir Y; Tosun S; Ermin S; Polat G; Yılmaz C; Bilaçeroğlu S; Salık B; Kömürcüoğlu B; Ödemiş İ; Köse Ş; Uzun U; Aydın G; İlhan E
    J Infect Dev Ctries; 2024 Apr; 18(4):513-519. PubMed ID: 38728641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination.
    Matrajt L; Eaton J; Leung T; Dimitrov D; Schiffer JT; Swan DA; Janes H
    Nat Commun; 2021 Jun; 12(1):3449. PubMed ID: 34103510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranking the relative importance of COVID-19 vaccination strategies in Canada: a priority-setting exercise.
    Zhao L; Ismail SJ; Tunis MC
    CMAJ Open; 2021; 9(3):E848-E854. PubMed ID: 34493551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza Vaccination and Hospitalizations Among COVID-19 Infected Adults.
    Yang MJ; Rooks BJ; Le TT; Santiago IO; Diamond J; Dorsey NL; Mainous AG
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S179-S182. PubMed ID: 33622834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    Yang C; Yang Y; Li Y
    PLoS One; 2021; 16(12):e0261236. PubMed ID: 34936650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.